Survey

/Survey

Patient Input – Treatment with Telotristat

TELOTRISTAT is an adjunct to somatostatin analogue therapy for the long-term treatment of carcinoid syndrome to improve symptom control in adult patients with metastatic neuroendocrine tumours.The company who makes telotristat [...]

By | 2018-09-03T18:47:17+00:00 September 3rd, 2018|Survey, Treatment News|Comments Off on Patient Input – Treatment with Telotristat

NET Research Priorities Survey Results

In March CNETS Canada reached out to the patient community through an online, anonymous survey to gather feedback and input on setting the research priorities for CNETS Canada sponsored grants [...]

By | 2018-09-22T00:19:01+00:00 August 15th, 2018|Research, Survey|Comments Off on NET Research Priorities Survey Results